Combined pretreatment serum CA19-9 and neutrophil-to-lymphocyte ratio as a potential prognostic factor in metastatic pancreatic cancer patients

por Song, Jian-Yuan, Chen, Ming-Qiu, Guo, Jing-Hua, Lian, Shi-Feng, Xu, Ben-Hua
Publicado 2018

The survival benefit of intensified full-dose XELOX chemotherapy concomitant to radiotherapy and then resting-period consolidation chemotherapy in locally advanced rectal cancer

por Zheng, Rong, Lian, ShiFeng, Huang, XiaoXue, Guan, GuoXian, Li, XiaoBo, Chi, Pan, Xu, BenHua
Publicado 2019